Position in SCLX
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$109
+$16 QoQ
Shares Held
14
-36.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 72 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacifica Partners Inc. holds $7,399,924 across 11 Drug Manufacturers - General names. SCLX ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,013 | $5,590,641 | |
| 2 | ABBV |
AbbVie Inc.
|
1,990 | $500,763 | |
| 3 | LLY |
ELI LILLY & Co
|
328 | $393,413 | |
| 4 | AMGN |
Amgen Inc
|
967 | $350,170 | |
| 5 | NVS |
Novartis AG
|
1,984 | $310,932 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,482 | $190,437 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
310 | $39,165 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
230 | $13,252 |
All Filings in SCLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109 | 14 | Shares | Defined | 2026-07-13 | |
| 2026-03-31 | $93 | 14 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $170 | 14 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $275 | 14 | Shares | Defined | 2025-10-09 | |
| 2023-12-31 | $1,005 | 493 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $690 | 493 | Shares | Defined | 2023-10-10 | |
| No filing history on record for this holder in this stock. | ||||||